The company launched in 2023 with $90 million in funding from organizations including Johnson & Johnson’s venture capital arm.
AVID Medical, Aligned Medical Solutions, Medical Action Industries and American Contract Systems all sent notices to ...
The decision to wind down the operation in Santa Rosa in about two years comes as the medtech giant combines several ...
The deal for Amplitude’s intravascular lithotripsy platform, which closed last week, included $435 million upfront and up to ...
The new version of Tandem’s Mobi pump would be the diabetes technology company’s first tubeless device. Tandem Diabetes Care ...
Makary’s exit ends a turbulent run marred by leadership upheaval, mass layoffs, political pressure and public spats with ...
With a recent initial public offering, CEO Richard Foust hopes to make the company’s vagus nerve stimulation treatment the ...
BD named Vitor Roque as chief financial officer Thursday, ending the medtech company’s seven-month search for a permanent ...
Created by Johns Hopkins University researchers, the early warning system for sepsis aims to help physicians detect the ...
Investors including Bezos Expeditions and Thiel Bio supported HistoSonics’ expansion plans last year by participating in a ...
Johnson & Johnson has launched a new iteration of its Shockwave coronary intravascular lithotripsy catheter that is designed to make it easier for physicians to treat complex calcified lesions and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results